Stroke:可卡因增动脉瘤蛛网膜下腔出血患者院内死亡风险

2013-05-10 高晓方 译 医学论坛网

  美国一项研究表明,在动脉瘤蛛网膜下腔出血(aSAH)患者中,可卡因急性应用与动脉瘤再破裂和院内死亡风险升高相关。论文5月7日在线发表于《卒中》(Stroke)。   此项研究共纳入1134例aSAH患者。从中确定可卡因急性应用者,并与近期无可卡因暴露的患者加以比较;比较内容包括就诊表现、动脉瘤再破裂和迟发性脑缺血等并发症以及院内死亡率和功能转归等转归指标。   结果显示,共有142例(12

  美国一项研究表明,在动脉瘤蛛网膜下腔出血(aSAH)患者中,可卡因急性应用与动脉瘤再破裂和院内死亡风险升高相关。论文5月7日在线发表于《卒中》(Stroke)。

  此项研究共纳入1134例aSAH患者。从中确定可卡因急性应用者,并与近期无可卡因暴露的患者加以比较;比较内容包括就诊表现、动脉瘤再破裂和迟发性脑缺血等并发症以及院内死亡率和功能转归等转归指标。

  结果显示,共有142例(12.5%)患者与可卡因应用相关。可卡因应用者更为年轻的可能性较大(P<0.001)。两组患者在Hunt-Hess分级不佳、相关性脑室内出血和入院头颅CT脑积水发生率方面无显著差异。在可卡因应用者中动脉瘤破裂发生率较高(P<0.05)。对其他因素进行校正之后,可卡因应用与迟发型脑缺血风险较高无显著相关性。可卡因应用者的出院存活可能性低于非应用者;其院内死亡的校正机率升高2.9倍(P<0.001)。两组患者的功能转归无差异。

蛛网膜相关的拓展阅读:


Impact of Acute Cocaine Use on Aneurysmal Subarachnoid Hemorrhage.
BACKGROUND AND PURPOSE
Acute cocaine use has been temporally associated with aneurysmal subarachnoid hemorrhage (aSAH). This study analyzes the impact of cocaine use on patient presentation, complications, and outcomes.
METHODS
Data of patients admitted with aSAH between 1991 and 2009 were reviewed to determine impact of acute cocaine use (C). These patients were compared with aSAH patients without recent cocaine exposure (NC) in relation to their presentation, complications such as aneurysmal rerupture and delayed cerebral ischemia, and outcomes including hospital mortality and functional outcome.
RESULTS
Data of 1134 aSAH patients were reviewed; 142 patients (12.5%) had associated cocaine use. Cocaine users were more likely to be younger (mean age: C, 49±11; NC, 53±14; P<0.001). There were no differences in rates of poor-grade Hunt and Hess (4-5); (C, 21%; NC, 26%; P>0.05), associated intraventricular hemorrhage (C, 56%; NC, 51%; P>0.05), or hydrocephalus on admission Head CT (C, 49%; NC, 52%; P>0.05). Aneurysm rerupture incidence was higher among cocaine users (C, 7.7%; NC, 2.7%; P<0.05). The association of cocaine use with higher risk of delayed cerebral ischemia (C, 22%; NC, 16%; P<0.05) was not significant after correcting for other factors. Cocaine users were less likely to survive hospitalization compared with nonusers (mortality: C, 26%; NC, 17%; P<0.05); the adjusted odds of hospital mortality were 2.9 times higher among cocaine users (P<0.001). There were no differences in functional outcomes between the 2 groups.
CONCLUSIONS
Acute cocaine use was associated with a higher risk of aneurysm rerupture and hospital mortality after aSAH.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1654403, encodeId=45a716544032d, content=<a href='/topic/show?id=5ab788e81d3' target=_blank style='color:#2F92EE;'>#蛛网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88781, encryptionId=5ab788e81d3, topicName=蛛网膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=396c24497244, createdName=aliceclz, createdTime=Mon Feb 17 07:47:00 CST 2014, time=2014-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635223, encodeId=73ac1635223a7, content=<a href='/topic/show?id=bb41983049e' target=_blank style='color:#2F92EE;'>#院内死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98304, encryptionId=bb41983049e, topicName=院内死亡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78f122436081, createdName=yuhaisheng_ibp_32061718, createdTime=Sun Oct 20 03:47:00 CST 2013, time=2013-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957277, encodeId=bb3f195e27737, content=<a href='/topic/show?id=3c293328175' target=_blank style='color:#2F92EE;'>#动脉瘤蛛网膜下腔出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33281, encryptionId=3c293328175, topicName=动脉瘤蛛网膜下腔出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=198d2500149, createdName=12498bd5m16暂无昵称, createdTime=Wed Aug 21 17:47:00 CST 2013, time=2013-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255440, encodeId=d943125544004, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sun May 12 01:47:00 CST 2013, time=2013-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481670, encodeId=147c14816e0e8, content=<a href='/topic/show?id=7099384244c' target=_blank style='color:#2F92EE;'>#可卡因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38424, encryptionId=7099384244c, topicName=可卡因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbbf7815801, createdName=12498b3em10(暂无昵称), createdTime=Sun May 12 01:47:00 CST 2013, time=2013-05-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1654403, encodeId=45a716544032d, content=<a href='/topic/show?id=5ab788e81d3' target=_blank style='color:#2F92EE;'>#蛛网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88781, encryptionId=5ab788e81d3, topicName=蛛网膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=396c24497244, createdName=aliceclz, createdTime=Mon Feb 17 07:47:00 CST 2014, time=2014-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635223, encodeId=73ac1635223a7, content=<a href='/topic/show?id=bb41983049e' target=_blank style='color:#2F92EE;'>#院内死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98304, encryptionId=bb41983049e, topicName=院内死亡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78f122436081, createdName=yuhaisheng_ibp_32061718, createdTime=Sun Oct 20 03:47:00 CST 2013, time=2013-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957277, encodeId=bb3f195e27737, content=<a href='/topic/show?id=3c293328175' target=_blank style='color:#2F92EE;'>#动脉瘤蛛网膜下腔出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33281, encryptionId=3c293328175, topicName=动脉瘤蛛网膜下腔出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=198d2500149, createdName=12498bd5m16暂无昵称, createdTime=Wed Aug 21 17:47:00 CST 2013, time=2013-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255440, encodeId=d943125544004, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sun May 12 01:47:00 CST 2013, time=2013-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481670, encodeId=147c14816e0e8, content=<a href='/topic/show?id=7099384244c' target=_blank style='color:#2F92EE;'>#可卡因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38424, encryptionId=7099384244c, topicName=可卡因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbbf7815801, createdName=12498b3em10(暂无昵称), createdTime=Sun May 12 01:47:00 CST 2013, time=2013-05-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1654403, encodeId=45a716544032d, content=<a href='/topic/show?id=5ab788e81d3' target=_blank style='color:#2F92EE;'>#蛛网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88781, encryptionId=5ab788e81d3, topicName=蛛网膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=396c24497244, createdName=aliceclz, createdTime=Mon Feb 17 07:47:00 CST 2014, time=2014-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635223, encodeId=73ac1635223a7, content=<a href='/topic/show?id=bb41983049e' target=_blank style='color:#2F92EE;'>#院内死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98304, encryptionId=bb41983049e, topicName=院内死亡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78f122436081, createdName=yuhaisheng_ibp_32061718, createdTime=Sun Oct 20 03:47:00 CST 2013, time=2013-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957277, encodeId=bb3f195e27737, content=<a href='/topic/show?id=3c293328175' target=_blank style='color:#2F92EE;'>#动脉瘤蛛网膜下腔出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33281, encryptionId=3c293328175, topicName=动脉瘤蛛网膜下腔出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=198d2500149, createdName=12498bd5m16暂无昵称, createdTime=Wed Aug 21 17:47:00 CST 2013, time=2013-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255440, encodeId=d943125544004, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sun May 12 01:47:00 CST 2013, time=2013-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481670, encodeId=147c14816e0e8, content=<a href='/topic/show?id=7099384244c' target=_blank style='color:#2F92EE;'>#可卡因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38424, encryptionId=7099384244c, topicName=可卡因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbbf7815801, createdName=12498b3em10(暂无昵称), createdTime=Sun May 12 01:47:00 CST 2013, time=2013-05-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1654403, encodeId=45a716544032d, content=<a href='/topic/show?id=5ab788e81d3' target=_blank style='color:#2F92EE;'>#蛛网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88781, encryptionId=5ab788e81d3, topicName=蛛网膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=396c24497244, createdName=aliceclz, createdTime=Mon Feb 17 07:47:00 CST 2014, time=2014-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635223, encodeId=73ac1635223a7, content=<a href='/topic/show?id=bb41983049e' target=_blank style='color:#2F92EE;'>#院内死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98304, encryptionId=bb41983049e, topicName=院内死亡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78f122436081, createdName=yuhaisheng_ibp_32061718, createdTime=Sun Oct 20 03:47:00 CST 2013, time=2013-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957277, encodeId=bb3f195e27737, content=<a href='/topic/show?id=3c293328175' target=_blank style='color:#2F92EE;'>#动脉瘤蛛网膜下腔出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33281, encryptionId=3c293328175, topicName=动脉瘤蛛网膜下腔出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=198d2500149, createdName=12498bd5m16暂无昵称, createdTime=Wed Aug 21 17:47:00 CST 2013, time=2013-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255440, encodeId=d943125544004, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sun May 12 01:47:00 CST 2013, time=2013-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481670, encodeId=147c14816e0e8, content=<a href='/topic/show?id=7099384244c' target=_blank style='color:#2F92EE;'>#可卡因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38424, encryptionId=7099384244c, topicName=可卡因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbbf7815801, createdName=12498b3em10(暂无昵称), createdTime=Sun May 12 01:47:00 CST 2013, time=2013-05-12, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1654403, encodeId=45a716544032d, content=<a href='/topic/show?id=5ab788e81d3' target=_blank style='color:#2F92EE;'>#蛛网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88781, encryptionId=5ab788e81d3, topicName=蛛网膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=396c24497244, createdName=aliceclz, createdTime=Mon Feb 17 07:47:00 CST 2014, time=2014-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635223, encodeId=73ac1635223a7, content=<a href='/topic/show?id=bb41983049e' target=_blank style='color:#2F92EE;'>#院内死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98304, encryptionId=bb41983049e, topicName=院内死亡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78f122436081, createdName=yuhaisheng_ibp_32061718, createdTime=Sun Oct 20 03:47:00 CST 2013, time=2013-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957277, encodeId=bb3f195e27737, content=<a href='/topic/show?id=3c293328175' target=_blank style='color:#2F92EE;'>#动脉瘤蛛网膜下腔出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33281, encryptionId=3c293328175, topicName=动脉瘤蛛网膜下腔出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=198d2500149, createdName=12498bd5m16暂无昵称, createdTime=Wed Aug 21 17:47:00 CST 2013, time=2013-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255440, encodeId=d943125544004, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sun May 12 01:47:00 CST 2013, time=2013-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481670, encodeId=147c14816e0e8, content=<a href='/topic/show?id=7099384244c' target=_blank style='color:#2F92EE;'>#可卡因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38424, encryptionId=7099384244c, topicName=可卡因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbbf7815801, createdName=12498b3em10(暂无昵称), createdTime=Sun May 12 01:47:00 CST 2013, time=2013-05-12, status=1, ipAttribution=)]

相关资讯

可卡因可致心血管系统急、慢性损害

   美国心脏学会(AHA)2012科学年会公布的一项研究表明,其他方面均健康的可卡因规律应用者可出现血压、主动脉血管硬度和左心室质量升高。    此项研究共纳入20例规律可卡因应用者(每周1至2次)和20例非应用者。两组受试者在年龄、性别以及自报血脂异常、糖尿病和高血压病史方面均相似,但可卡因应用者平均体表面积较大,并且吸烟、饮酒或应用其他休闲类药物应用的可能性较高。至少在受试者末次应用可卡因

Mol Psychiatr:长期服用可卡因加速大脑老化

近日有研究表明,长期使用者的大脑年龄大大快于未接触可卡因的人。 英国剑桥大学的科学家的新研究表明:长期滥用可卡因会加速大脑衰老过程。相关研究论文发表在4月25日的Molecular Psychiatry杂志上,该研究发现与健康人群相比,可卡因会让年龄有关的大脑中的灰质损失得更严重。 在这项研究中,研究人员扫描了年龄相近、性别一致以及智商相似的120人的大脑。有一半人依赖可卡因,而其他60人没有